The effect of resveratrol supplementation on serum levels of asymmetric de‐methyl‐arginine and paraoxonase 1 activity in patients with type 2 diabetes: A randomized, double‐blind controlled trial-Reference-Cited by-同舟云学术

The effect of resveratrol supplementation on serum levels of asymmetric de‐methyl‐arginine and paraoxonase 1 activity in patients with type 2 diabetes: A randomized, double‐blind controlled trial

Published:2020-03-06 Issue:8 Volume:34 Page:2023-2031
ISSN:0951-418X
Container-title:Phytotherapy Research
language:en
Short-container-title:Phytotherapy Research

Author:

Tabatabaie Mahtab¹²,Abdollahi Shima³,Salehi‐Abargouei Amin¹²,Clark Cain C. T.⁴,Karimi‐Nazari Elham²,Fallahzadeh Hossein⁵,Rahmanian Masoud⁶,Mozaffari‐Khosravi Hassan¹⁶

Affiliation:

1. Department of NutritionSchool of Public Health, Shahid Sadoughi University of Medical Sciences Yazd Iran

2. Nutrition and Food Security Research CenterShahid Sadoughi University of Medical Sciences Yazd Iran

3. Department of Nutrition and Public HealthSchool of Public Health, North Khorasan University Bojnurd Iran

4. Centre for Sport, Exercise, and Life SciencesCoventry University Coventry UK

5. Department of Biostatistics and Epidemiology, Research Center of Prevention and Epidemiology of Non‐Communicable DiseaseSchool of Health, Shahid Sadoughi University of Medical Sciences Yazd Iran

6. Yazd Diabetic Research CenterShahid Sadoughi University of Medical Sciences Yazd Iran

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ptr.6655

Reference74 articles.

1. Validation of a New Self-Report Instrument for Measuring Physical Activity

2. Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus

3. The effect of resveratrol supplementation on the expression levels of factors associated with cellular senescence and sCD163/sTWEAK ratio in patients with type 2 diabetes mellitus: study protocol for a double-blind controlled randomised clinical trial

4. The Effect of Resveratrol Supplementation on Cardio‐Metabolic Risk Factors in Patients with Type 2 Diabetes: A Randomized, Double‐Blind Controlled Trial

5. An Update on the Etiology and Epidemiology of Diabetes Mellitus

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities;International Journal of Molecular Sciences;2024-01-06

2. Phytochemicals for the treatment of metabolic diseases: Evidence from clinical studies;Biomedicine & Pharmacotherapy;2023-09

3. Targeting Oxidative Stress with Polyphenols to Fight Liver Diseases;Antioxidants;2023-06-03

4. Resveratrol improves diabetic cardiomyopathy by preventing asymmetric dimethylarginine-caused peroxisome proliferator-activated receptor-γ coactivator-1α acetylation;European Journal of Pharmacology;2022-12

5. Recent advances in the effects of dietary polyphenols on inflammation in vivo: potential molecular mechanisms, receptor targets, safety issues, and uses of nanodelivery system and polyphenol polymers;Current Opinion in Food Science;2022-12